Open Access
Open access
volume 8 issue 38 pages 62914-62926

MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6

Publication typeJournal Article
Publication date2017-04-29
scimago Q2
SJR0.785
CiteScore5.6
Impact factor
ISSN19492553
Oncology
Abstract
Aberrantly expressed microRNAs contribute to the initiation and progression of human cancer. MiRNA-187 has been reported in nasopharyngeal, renal, pancreatic, prostate, and esophageal cancer, and acts as a tumor suppressor or oncogene. However, the underlying function of miRNA-187 in cervical cancer remains largely unexplored. In the present study, we demonstrated significantly miRNA-187 down-regulation in cervical cancer tissues and cell lines compared to their normal counterparts. Kaplan-Meier analysis revealed that decreased miRNA-187 was closely associated with shorter overall survival and relapse-free survival. Gain- and loss-of-function studies showed that miRNA-187 suppressed cervical cancer cell proliferation, migration, and invasion, and promoted cervical cancer cell apoptosis. Furthermore, luciferase reporter assay determined that human papillomavirus 16 E6 was a direct functional target of miRNA-187. Taken together, our findings indicate the essential role of miRNA-187 in suppressing cervical cancer progression and indicate a novel link between miRNA-187 and human papillomavirus 16 E6 in cervical cancer.
Found 
Found 

Top-30

Journals

1
Oncotarget
1 publication, 5.26%
Bioscience Reports
1 publication, 5.26%
Oncology Letters
1 publication, 5.26%
Infectious Agents and Cancer
1 publication, 5.26%
Cells
1 publication, 5.26%
Journal of Dental Sciences
1 publication, 5.26%
Antiviral Research
1 publication, 5.26%
Archives of Biochemistry and Biophysics
1 publication, 5.26%
Chemico-Biological Interactions
1 publication, 5.26%
Biomedicine and Pharmacotherapy
1 publication, 5.26%
Journal of Cellular Biochemistry
1 publication, 5.26%
Journal of Cellular Physiology
1 publication, 5.26%
Neuroscience and Biobehavioral Reviews
1 publication, 5.26%
Bioengineered
1 publication, 5.26%
Cancer Biology and Therapy
1 publication, 5.26%
BioMed Research International
1 publication, 5.26%
Translational Cancer Research
1 publication, 5.26%
Advances in molecular oncology
1 publication, 5.26%
Biomarkers in Medicine
1 publication, 5.26%
1

Publishers

1
2
3
4
5
Elsevier
5 publications, 26.32%
Taylor & Francis
3 publications, 15.79%
Springer Nature
2 publications, 10.53%
Wiley
2 publications, 10.53%
Impact Journals
1 publication, 5.26%
Spandidos Publications
1 publication, 5.26%
MDPI
1 publication, 5.26%
Association for Dental Sciences of the Republic of China
1 publication, 5.26%
Hindawi Limited
1 publication, 5.26%
AME Publishing Company
1 publication, 5.26%
Publishing House ABV Press
1 publication, 5.26%
1
2
3
4
5
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
19
Share
Cite this
GOST |
Cite this
GOST Copy
Lin M. et al. MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6 // Oncotarget. 2017. Vol. 8. No. 38. pp. 62914-62926.
GOST all authors (up to 50) Copy
Lin M., Xue X., Liang S., Li Y., Lv Y., He L., Xu K., Zhang L., Chen J., Niu L. MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6 // Oncotarget. 2017. Vol. 8. No. 38. pp. 62914-62926.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.18632/oncotarget.17516
UR - https://doi.org/10.18632/oncotarget.17516
TI - MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6
T2 - Oncotarget
AU - Lin, Mao
AU - Xue, Xiang-Yang
AU - Liang, Shu-Zhen
AU - Li, Yinxiong
AU - Lv, You-Yong
AU - He, Lihua
AU - Xu, Ke-Cheng
AU - Zhang, Lifang
AU - Chen, Ji-Bing
AU - Niu, Li-Zhi
PY - 2017
DA - 2017/04/29
PB - Impact Journals
SP - 62914-62926
IS - 38
VL - 8
PMID - 28968959
SN - 1949-2553
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2017_Lin,
author = {Mao Lin and Xiang-Yang Xue and Shu-Zhen Liang and Yinxiong Li and You-Yong Lv and Lihua He and Ke-Cheng Xu and Lifang Zhang and Ji-Bing Chen and Li-Zhi Niu},
title = {MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6},
journal = {Oncotarget},
year = {2017},
volume = {8},
publisher = {Impact Journals},
month = {apr},
url = {https://doi.org/10.18632/oncotarget.17516},
number = {38},
pages = {62914--62926},
doi = {10.18632/oncotarget.17516}
}
MLA
Cite this
MLA Copy
Lin, Mao, et al. “MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6.” Oncotarget, vol. 8, no. 38, Apr. 2017, pp. 62914-62926. https://doi.org/10.18632/oncotarget.17516.